.png)
The 9th Annual West Oncology Conference serves as a valuable forum for presenting and discussing new research findings in oncology education.
Learners are provided updates on practice-changing data in breast cancers, genitourinary cancers, hematological malignancies, gastrointestinal cancers, and lung cancers – all in a practical and interactive format, fostering discussion and impacting patient clinical outcomes. This accredited meeting is an in-person conference with on-demand access for registered attendees.
Meeting registrations will require a credit card as a cancellation hold. A fee of $195 will only be incurred in the event of a no-show or cancellation within 14 days without written confirmation to the Total Health Program Team.
Program Chairs
.png)
Conference Agenda
.png)
Venue Information
Hilton Memphis
939 Ridge Lake Blvd, Memphis, TN 38120
Click Here to reserve your room
for $169 per night
Book by January 2, 2024
Group Code: 922
Accreditation Information | 6.75
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 6.75 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 6.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 6.75 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.55 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.
Learning Objectives
-
Identify novel targeted and immunologic approaches to therapy for various cancers
-
Integrate recent findings on healthcare disparities into optimal therapy selection for individual patients with cancer
-
Identify optimal therapies for patients and managing and mitigating side effects
-
Describe findings from recent clinical trials evaluating immunotherapies
-
Identify strategies to prevent and manage the treatment related adverse events of targeted therapies and immunotherapies to improve tolerability and maintain quality of life
-
Foster discussions on equitable and equal access and delivery of care for disparate populations, including discussing research and drug and diagnostic pipeline development that include underserved and underrepresented patients
What to Expect
In-Person Learners
-
Free registration for all healthcare providers
-
Expert sessions that present the most clinically relevant data, research, and clinical strategies
-
Enduring video content for watching at your leisure
-
Real-time discussion and debate
-
Networking with peers, colleagues, and medical professionals
-
Access to the latest industry information and resources
-
Catered meals through-out the program
-
Special in-person networking reception, catered and open bar